Dr Reddys Laboratories (RDY) Research & Development (2012 - 2026)

Dr Reddys Laboratories' Research & Development history runs 15 years deep, the most recent figure standing at $67.8 million for Q1 2026.

• In Q1 2026, Research & Development fell 19.05% year-over-year to $67.8 million; the TTM figure through Mar 2026 stood at $293.7 million (down 9.28% YoY), while the FY2026 annual figure was $256.0 million, down 20.0% from the prior year.
• Research & Development was $67.8 million for Q1 2026 at Dr Reddys Laboratories, down from $69.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $86.8 million in Q3 2024 to a low of $59.0 in Q3 2022.
• Historically, Research & Development has averaged $65.8 million across 5 years, with a median of $67.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development sank 100.0% in 2022, then jumped 111681741.53% in 2023.
• A 5-year view of Research & Development shows it stood at $65.0 million in 2022, then climbed by 2.82% to $66.8 million in 2023, then increased by 17.98% to $78.9 million in 2024, then decreased by 12.43% to $69.1 million in 2025, then fell by 1.75% to $67.8 million in 2026.
• The last three Research & Development figures came in at $67.8 million (Q1 2026), $69.1 million (Q4 2025), and $73.0 million (Q2 2025), per Business Quant data.